Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Glipizide

A sulfonylurea for type 2 diabetes, developed in Milan in the late 1960s and in use since 1971 (in the United States since 1984): it stimulates the beta cells of the pancreas to release insulin. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.

Did you know?Its half-life is only 2 to 5 hours, yet its effect on blood sugar can last up to a whole day.

GlipizideGo to the active ingredient →
GlipizideActive ingredientGlipizideCat. No. P-G042-001CAS 29094-61-9
Glipizide-d11Isotopically labelledGlipizide-d11Cat. No. P-G042-011CAS 1189426-07-0

EDQM standards 4

The official European Pharmacopoeia standards for this family.

Reference substanceGlipizide CRSEDQM code G0340000Family Glipizide

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.